IP Library Granted Patent US 11,950,925
Granted Patent B2
US 11,950,925 · App. 18/296,292 · Granted Apr 9, 2024

Managing fluid levels in a patient and associated devices, systems, and methods

Inventors: Howard R. Levin (Teaneck, NJ); Jim Dillon (Milford, MA); Andrew Halpert (Brookline, MA); Jeffrey Testani (New Haven, CT)
Assignee: REPRIEVE CARDIOVASCULAR, INC.
A61B5/4839A61B5/208A61M5/142A61M2005/14208A61M2202/0496A61M2205/3327A61M2205/3396A61M2205/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,950,925
App. No.
18/296,292
Granted
Apr 9, 2024
Kind
B2
Abstract

Devices, systems, and methods for delivering fluid therapy to a patient are disclosed herein. An exemplary method can comprise obtaining a urine output rate from a patient; causing a diuretic to be provided to the patient at a dosage rate, wherein the dosage rate is increased over a period of time such that the urine output rate increases to be above a predetermined threshold within the period of time; and causing a hydration fluid to be provided to the patient at a hydration rate. The hydration rate can be set based on the urine output rate to drive net fluid loss from the patient.

Claims (34)

1. A fluid therapy system comprising:

one or more processors; and

tangible, non-transitory computer-readable media having instructions that, when executed by the one or more processors, cause the fluid therapy system to perform operations to cause a net fluid loss from the patient, the operations comprising—

receiving a first indication that urine output of a patient is at or above a first urine output threshold and below a second urine output threshold;

based on and after receiving the first indication, causing hydration fluid to be infused to the patient at a first hydration fluid rate, such that a first difference exists between the first hydration fluid rate and the urine output of the patient when the first indication is received, wherein the first hydration fluid rate is less than a first predetermined rate while the urine output is below the second urine output threshold;

receiving a second indication that the urine output is at or above the second urine output threshold; and

based on and after receiving the second indication, causing the hydration fluid to be infused at a second hydration fluid rate at or above the first hydration fluid rate, such that a second difference exists between the second hydration fluid rate and the urine output rate when the second indication is received, wherein the second difference is greater than the first difference, and wherein the second hydration fluid rate is less than the urine output.

2. The fluid therapy system of claim 1 , wherein:

when the urine output of the patient is between the first urine output threshold and the second urine output threshold, the urine output is greater than the first hydration fluid rate by a first amount,

when the urine output of the patient is between the second urine output threshold and a third urine output threshold greater than the second urine output threshold, the urine output is greater than the second hydration fluid rate by a second amount, and

the second amount is greater than the first amount.

3. The fluid therapy system of claim 1 , wherein the operations further comprise:

receiving a third indication that the urine output is at or above a third urine output threshold, wherein the third urine output threshold is above the second urine output threshold; and

after receiving the third indication, causing the hydration fluid to be infused at a third hydration fluid rate at or above the second hydration fluid rate.

4. The fluid therapy system of claim 3 , wherein the operations further comprise:

receiving a fourth indication that the urine output is at or above a fourth urine output threshold, wherein the fourth urine output threshold is above the third urine output threshold; and

after receiving the fourth indication, causing the hydration fluid to be infused at a fourth hydration fluid rate at or above the third hydration fluid rate.

5. The fluid therapy system of claim 3 , wherein:

causing the hydration fluid to be infused at the first hydration fluid rate is configured to correspond to a first net fluid balance of the patient,

causing the hydration fluid to be infused at the second hydration fluid rate is configured to correspond to a second net fluid balance of the patient less than the first net fluid balance, and

causing the hydration fluid to be infused at the third hydration fluid rate is configured to correspond to a third net fluid balance of the patient less than the second net fluid balance.

6. The fluid therapy system of claim 1 , further comprising a first pump configured to provide the hydration fluid to the patient and a second pump configured to provide a diuretic to the patient.

7. The fluid therapy system of claim 1 , wherein the operations further comprise, when the urine output is below the first urine output threshold, not causing the hydration fluid to be infused.

8. The fluid therapy system of claim 1 , further comprising, prior to causing the hydration fluid to be infused to the patient at the first hydration fluid rate, causing the hydration fluid to be infused to the patient at an initial infusion rate, wherein the first hydration fluid rate is higher than the initial infusion rate.

9. A fluid therapy system comprising:

one or more processors; and

tangible, non-transitory computer-readable media having instructions that, when executed by the one or more processors, cause the fluid therapy system to perform operations comprising—

receiving a first indication that urine output of a patient is at or above a first urine output threshold and below a second urine output threshold;

after receiving the first indication, causing hydration fluid to be infused to the patient at a first hydration fluid rate, wherein the first hydration fluid rate is less than a first predetermined rate while the urine output is below the second urine output threshold;

receiving a second indication that the urine output is at or above the second urine output threshold; and

after receiving the second indication, causing the hydration fluid to be infused at a second hydration fluid rate at or above the first hydration fluid rate, wherein the second hydration fluid rate is less than the urine output,

receiving a third indication that the urine output is at or above a third urine output threshold, wherein the third urine output threshold is above the second urine output threshold; and

after receiving the third indication, causing the hydration fluid to be infused at a third hydration fluid rate at or above the second hydration fluid rate,

wherein the first urine output threshold is at least 175 milliliters/hour, and the second urine output threshold is at least 375 milliliters/hour.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2023
From: LEVIN, HOWARD R.; DILLON, JIM; HALPERT, ANDREW; TESTANI, JEFFREY
To: REPRIEVE CARDIOVASCULAR, INC.
Reel/Frame 063464/0364 →
Continuity (4)
Continuation 17806681 · Jun 13, 2022
Continuation 17112925 · Dec 4, 2020
Provisional Application 62945058 · Dec 6, 2019
Related Publication 20230240600A1 · Aug 3, 2023
Cited By (7)
US 12,239,819 US 12,257,416 US 12,290,380 US 12,303,271 US 12,471,842 US 12,582,773 US 12,605,702